GHRS:NASDAQ, GH Research PLC

GHRS stock overview

GH Research PLC (GHRS:NASDAQ) closed at $18.15 on October 16, 2026, down 3.51% on the day. The stock trades 42.3% below its 52-week high of $31.44 and 50.7% above its 52-week low of $12.04. Over the past year, it gained 34.5%. GH Research PLC is part of the Health Care sector.

Key figures

Price
$18.15
Day change
-3.51%
Volume
162,602
Average volume
283,901
Market cap
1B+
52-week range
$12.04 – $31.44
50-day average
$26.30
200-day average
$21.30

Performance

5D 1M 3M 6M 1Y
-9.34% -36.80% -34.07% -15.58% +34.54%

Price action over the past year

In 252 trading sessions since October 16, 2025, GHRS closed higher on 128 days (51%). Its best day was January 7, 2026 (+27.12%) and its worst was January 8, 2026 (-13.37%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

GHRS news

About GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Similar stocks

Find more stocks like GHRS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.